Kevin G Burfeind - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kevin G Burfeind

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Nature Communications|April 7, 2021

Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexiaBrennan Olson, Xinxia Zhu, Mason A Norgard, et al.

Nature Communications|November 16, 2019

Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.

Nature Communications|October 17, 2019

The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.

Brain Research Bulletin|November 24, 2018

Baseline characterization of epilepsy in an onchocerciasis endemic area of the Democratic Republic of CongoKevin G Burfeind, Jean-Marie K Kashama, Béatrice K Bora, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Nature Communications|April 7, 2021

Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexiaBrennan Olson, Xinxia Zhu, Mason A Norgard, et al.

Nature Communications|November 16, 2019

Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.

Nature Communications|October 17, 2019

The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.

Brain Research Bulletin|November 24, 2018

Baseline characterization of epilepsy in an onchocerciasis endemic area of the Democratic Republic of CongoKevin G Burfeind, Jean-Marie K Kashama, Béatrice K Bora, et al.

Pageof 3